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Highlights 19 
 Bovine digital dermatitis (DD), DD treponemes, DD risk factors and DD control 20 
strategies are reviewed. 21 
 DD lesions, hoof trimming tools and bovine GI tract are DD infection reservoirs. 22 
 Improved hygiene and foot trimming practice could help prevent DD transmission. 23 
 Current antibiotic treatments are not the most effective against DD treponemes. 24 
 New antibiotics, additional transmission prevention and/or effective vaccines are needed. 25 
 26 
 27 
Abstract 28 
Bovine digital dermatitis (DD) is a severe infectious disease causing lameness in dairy 29 
cattle worldwide and is an important ruminant welfare problem that has considerable economic 30 
issues. Bovine DD is endemic in many regions worldwide and it is important to understand this 31 
major disease so that effective control strategies can be identified. There is substantial evidence 32 
that specific treponeme phylotypes play an important causative role in bovine DD. This review 33 
considers current research, including DD Treponema spp. investigations, associated DD 34 
pathobiology, and current and potential treatment and control options. Epidemiological data, 35 
alongside new microbiological data, help to delineate important transmission routes and 36 
reservoirs of infection that allow effective interventions to be identified. Better on-farm housing 37 
hygiene, pasture access, routine footbathing and claw trimming with disinfected equipment need 38 
to be implemented to significantly reduce the incidence of DD. There is a paucity of peer 39 
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reviewed research into both commonly used and novel treatments. In vitro antimicrobial 40 
susceptibility studies of DD treponemes and effective treatment of human treponematoses clearly 41 
indicate that antibiotics frequently selected for DD treatments are not the most efficacious. Whilst 42 
there are understandable concerns over milk withdrawal times in dairy cattle, more needs to be 43 
done to identify, license and implement more appropriate antibiotic treatments, since continued 44 
overuse of less efficacious antibiotics, applied incorrectly, will lead to increased disease 45 
recurrence and transmission. More research is needed into methods of preventing DD that 46 
circumvent the use of antibiotics, including vaccination and transmission blocking studies, in 47 
order to reduce or hopefully eradicate DD in the future. 48 
 49 
Keywords: Bovine digital dermatitis; Papillomatous digital dermatitis; Treponemes; Spirochaetes50 
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Introduction 51 
Bovine digital dermatitis (DD) was first reported in the 1970s (Cheli and Mortellaro, 52 
1974) and is also called Mortellaro’s disease in Europe, whereas papillomatous DD (PDD) or 53 
hairy foot/heel-warts (Read and Walker, 1998) is frequently used in North and South America 54 
and Australasia. The contagious nature of this severe disease and poor treatment response has 55 
resulted in a major worldwide problem in nearly all countries with dairy cattle. Substantial focal 56 
lesions on one or both rear feet of cattle are the typical presentation of DD, which is often 57 
extremely painful. The ensuing lameness is an important animal health and welfare concern, 58 
resulting in reduced milk yield and reproductive performance, with substantial costs of treatment 59 
and control. An effective prevention or treatment capable of eliminating bovine DD has yet to be 60 
identified. Spirochaetes and, more specifically, treponemes have been implicated as important in 61 
the aetiology of DD. This review discusses worldwide research that advances our understanding 62 
of current concepts in DD and the role of associated treponemes, with implications for best 63 
practices. 64 
 65 
Presentation, epidemiology and impact of the disease 66 
The main clinical feature of bovine DD is lameness resulting from an ulcerative lesion 67 
consisting of an extensive or localised superficial dermatitis immediately on or above the 68 
coronary band between the heel bulbs (Weaver et al., 1981; Blowey and Sharp, 1988). The 69 
majority of lesions (~80-90%) are typically found on hind feet, with far fewer occurring on the 70 
front feet (~10-20%) (Murray et al., 2002). Animals with DD are frequently severely lame and, as 71 
a result, may walk on their toes or shift their weight from foot to foot (Cheli and Mortellaro, 72 
1974; Read and Walker, 1998). Lesions adjacent to the interdigital space often extend locally to 73 
involve interdigital skin (Read and Walker 1994) and long standing lesions frequently (42%) 74 
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develop wart-like papillary keratotic proliferations (Read and Walker, 1998). A relevant scoring 75 
system for DD based on macroscopic lesion characteristics has been described (Dopfer et al., 76 
1997) and recently adapted, now including six stages (Berry et al., 2012) (Table 1). 77 
 78 
In the 20 years following the initial report from Italy (Cheli and Mortellaro, 1974), bovine 79 
DD subsequently appeared across the world, being reported in the USA (Rebhun et al., 1980), 80 
UK (Blowey and Sharp, 1988) and Japan (Kimura et al., 1993). Bovine DD is now endemic in 81 
dairy cattle populations across several European countries, including Germany, the Netherlands, 82 
Denmark, France and the UK (Laven, 2001; Koenig et al., 2005; Holzhauer et al., 2006; Capion 83 
et al., 2008; Relun et al., 2013), and the USA, including California, Georgia, Iowa and Wisconsin 84 
(Read and Walker, 1998; Brown et al., 2000; Faust et al., 2001). Globally, the problem is now 85 
common and there have also been case reports of DD from Egypt, South Africa, Turkey, Chile, 86 
Brazil, Canada and New Zealand (van Amstel et al., 1995; Rodriguez-Lainz et al., 1998; Cruz et 87 
al., 2001; el-Ghoul and Shaheed, 2001; Demirkan and Güzel, 2004; Vermunt and Hill, 2004; 88 
Cramer et al., 2009). 89 
 90 
The impact of bovine DD is considerable. Bovine DD can cause severe pain, making it an 91 
important animal welfare issue (Bruijnis et al., 2012), especially considering the number of 92 
animals worldwide with this disease. Furthermore, bovine DD is an important worldwide 93 
economic issue, since it results in reduced milk yields and reproductive performance (Argaez-94 
Rodriguez et al., 1997). The economic impact resulting from milk production losses in the USA 95 
has been calculated at US$190 million
1
 per year (Losinger, 2006). In the UK, the cost of bovine 96 
                                                          
1
 US$1.00 = UK£0.61 = €0.78 at 25 September 2014. 
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DD has been estimated at UK£99.00 per case (GB Cattle Health and Welfare Group, 2014), 97 
whilst in The Netherlands, the cost per dairy holding of 65 cows was estimated at 98 
US$1,517.00/year including milk loss and treatment costs (Bruijnis et al., 2010). Another study 99 
reported the cost as US$132.96 per case of DD consisting of US$35.41 for milk loss, US$41.37 100 
for decreased fertility and US$56.18 for treatment costs (Cha et al., 2010). Therefore bovine DD 101 
has substantial economic implications. 102 
 103 
Aetiology 104 
Epidemiological evidence, such as geographic spread and healing after antibiotic 105 
treatment, has implicated bovine DD as an infectious disease caused by bacteria (Read and 106 
Walker, 1998). Initially, the aetiology of DD was unclear, mainly due to the plethora of 107 
microorganisms present on the lesion surface as a result of the slurry environment that many 108 
dairy cows stand in. Various types of bacteria have been identified within bovine DD 109 
manifestations, including spirochaetes, Bacterioides spp., Guggenheimella bovis, Campylobacter 110 
spp., Fusobacterium spp. and Peptococccus spp. (Blowey and Sharp, 1988; Sabo et al., 1988; 111 
Read et al., 1992; Koniarova et al., 1993; Blowey et al., 1994; Dopfer et al., 1997; Schlafer et al., 112 
2008). A recent systematic microbiological study of DD anaerobes and aerobes additionally 113 
reported Porphyromonas levii, Mycoplasma spp., Prevotella spp. and spirochaetes as lesion 114 
associated (Berry et al., 2010). However, when considering all studies in entirety, the 115 
spirochaetes and specifically treponemes are the only microorganisms where there is substantial 116 
evidence of an aetiological association. 117 
 118 
An initial study involving cloning and sequencing of bacterial 16S rRNA genes from 119 
bovine DD lesions in Germany identified five phylotypes of treponemes within lesions (Choi et 120 
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al., 1997). Subsequent immunohistochemistry with molecular detection methods demonstrated 121 
both large numbers of treponemes within bovine DD lesions (Dopfer et al., 1997; Demirkan et 122 
al., 1998; Moter et al., 1998). Eight spirochaetes were isolated from bovine DD lesions in the 123 
USA, with seven forming a distinct phenotypic group (Walker et al., 1995); subsequently, a 124 
German BDD spirochaete (Treponema brennaborense) was reported to be quite different 125 
(Schrank et al., 1999). A genetic typing study of six isolates from the USA identified three 126 
phylotypes (Walker et al., 1995; Stamm et al., 2002). 127 
 128 
In a further study, four USA bovine DD spirochaetes were identified as similar to 129 
Treponema phagedenis (Trott et al., 2003). A spirochaete isolated from a UK BDD lesion was 130 
identified as similar to USA bovine DD isolates (Demirkan et al., 2006). Most recently, a larger 131 
number (n = 23) of treponemes from bovine DD lesions were isolated in the UK and were 132 
characterised both genotypically and phenotypically, demonstrating three distinct taxonomic 133 
groups analogous to USA DD phylotypes (Evans et al., 2008). In line with previous studies, these 134 
were designated as Treponema medium/Treponema vincentii-like, Treponema phagedenis-like 135 
and Treponema putidum/Treponema denticola-like spirochaetes. These phylogroups were very 136 
similar to human treponemes and therefore described as ‘-like’ (pending further taxonomic 137 
propositions) and by 16S rRNA gene phylogenetics were identical to 3/5 phylotypes identified in 138 
bovine DD lesions in the initial German study (Choi et al., 1997). Following additional 139 
characterisation, one isolated bovine DD treponeme phylogroup, the T. putidum/T. denticola-like, 140 
was designated as a new species, Treponema pedis (Evans et al., 2009b); the other two isolated 141 
phylogroups still require further taxonomic appraisal. 142 
 143 
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Immunohistochemistry and PCR assays targeting the three isolated phylotypes in the UK, 144 
along with German and Danish fluorescent in situ hybridisation (FISH) studies of bovine DD 145 
lesions, have identified multiple unique treponeme phylotypes together in bovine DD lesions, 146 
suggesting that the disease is polytreponemal rather than more broadly polymicrobial (Klitgaard 147 
et al., 2008; Nordhoff et al., 2008; Evans et al., 2009c). Subsequently, this hypothesis of multiple 148 
treponemal infection has being substantiated by further molecular metagenomic studies from 149 
Europe, Japan and the USA (Yano et al., 2010b; Santos et al., 2012; Klitgaard et al., 2013). 150 
Whilst similar DD treponemes have been isolated in the UK and USA; there have been some 151 
differences identified in the treponeme phylotypes highly associated with DD lesions between 152 
European countries such as Denmark and the UK suggesting regional differences in DD aetiology 153 
(Klitgaard et al., 2008; Evans et al., 2009). 154 
 155 
In hand with the considerable molecular evidence supporting specific treponeme 156 
phylotypes as playing an important causative role in DD, some workers have partially fulfilled 157 
Koch’s postulates towards definitively demonstrating a treponemal aetiology for bovine DD. 158 
Transmission has been previously demonstrated using foot inoculation of 4-month-old naive 159 
calves with lesional material (Read and Walker, 1996) and this was repeated recently using the 160 
same protocol on yearling cattle. In the latter experiment, lesional material achieved a lesion 161 
success rate of 4/6 animals, whereas a single treponeme isolate produced an incipient DD lesion 162 
in 1/4 animals (Gomez et al., 2012), suggesting that, if the experimental conditions were more 163 
optimal, a full-blown DD lesion may have developed. When experimental lesions were studied 164 
pathologically treponemes were the primary, predominant and the deepest invaders (Read et al. 165 
1998) suggesting they play an important pathogenic role in DD. In the above described 166 
experiments, cows’ feet were wrapped to reproduce conditions of prolonged moisture 167 
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(maceration) and reduced access to air before and after application of infectious material. Such 168 
conditions were required for transmission and could be considered to mimic the cows’ feet 169 
environment in a typical dairy farm unit. 170 
 171 
Similar disease manifestations in cattle 172 
New forms of bovine foot lesions have been described that previously were considered to 173 
be non-infectious, including toe necrosis, sole ulcers and white line disease. The new forms are 174 
chronic lesions that appear refractory to conventional treatment, are patently infected with 175 
bacteria, have a raised, red stippled appearance (granulation tissue) and the same pungent smell 176 
as bovine DD lesions. These non-healing foot lesions have a high association with DD 177 
treponemes (Blowey, 2008; Evans et al., 2011a), are particularly destructive and may have an 178 
even greater economic and animal welfare cost than DD itself. Ulcerative mammary dermatitis 179 
(UMD) also has an association with DD treponemes (Read et al., 2003; Stamm et al., 2009; 180 
Evans et al., 2010) although the association does not appear to be strong, suggesting that the 181 
disease may be more polymicrobial (Evans et al., 2010). 182 
 183 
'Digital dermatitis in non-bovine species' 184 
DD has now also emerged in sheep, causing contagious ovine DD (CODD), which was 185 
first reported in the UK as severe virulent ovine footrot (Harwood et al., 1997) and, after 186 
confirmation of treponeme involvement, reclassified as CODD (Davies et al., 1999). Treponemes 187 
have been implicated in CODD through serological and molecular studies (Dhawi et al., 2005; 188 
Moore et al., 2005; Sayers et al., 2009) although Dichelobacter nodosus may also have a role in 189 
this disease (Moore et al., 2005; Duncan et al., 2012). Furthermore a CODD-like infection has 190 
now been reported in dairy goats in the UK (Sullivan et al., 2015) and a similar manifestation has 191 
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been reported in Wild Elk in Washington State, USA (Clegg et al., 2015) suggesting an even 192 
greater economic, animal welfare and global cost of this disease. 193 
 194 
Treponeme phylotypes involved in DD have recently been implicated in porcine ear 195 
necrosis and shoulder ulcers in Sweden (Pringle et al., 2009; Karlsson et al., 2013). It appears 196 
that DD treponemes are continually emerging into new hosts and disease presentations, 197 
suggesting these bacteria pose a much greater threat than first conceived. 198 
 199 
Host genetics, immune and inflammatory responses 200 
There has been growing interest in host genetics of bovine DD in recent years. 201 
Heritability of bovine DD has been reported to be as low as 0.039 in one study (Onyiro et al., 202 
2008) and as high as 0.4 in another (Oberbauer et al., 2013), lending support for further 203 
heritability studies as well as genetic studies to identify loci contributing to DD susceptibility. 204 
Another study linked eight single nucleotide polymorphisms (SNPs), on three chromosomes, 205 
with dairy cattle DD susceptibility (Scholey et al., 2012). Larger studies are needed to further 206 
identify important loci and there is a need to develop diagnostic screening and targeted breeding 207 
to reduce the prevalence of DD. 208 
 209 
Pathological and immunohistochemical investigations of bovine DD lesions are described 210 
in Table 1. Lesions consistently have large numbers of spirochaetes invading the superficial skin 211 
layers, along with necrosis (Bassett et al., 1990; Read and Walker, 1994, 1998; Dopfer et al., 212 
1997). Infection with DD treponemes generates a strong but ineffective immune response for a 213 
relatively short duration (Demirkan et al., 1999; Trott et al., 2003), which neither resolves disease 214 
nor offers future protection. 215 
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 216 
In terms of inflammatory host responses, after in vitro exposure of bovine macrophages to 217 
bovine DD treponeme constituents, there is decreased expression of many genes associated with 218 
wound repair and immunity (Zuerner et al., 2007). Subsequent tissue culture studies have 219 
demonstrated that skin fibroblasts, but not keratinocytes, are responsive to BDD treponemes, 220 
producing macrophage elastase and RANTES, potentially important inflammatory mediators, 221 
which are also upregulated in human psoriasis (Evans et al., 2014). A host transcriptomics study 222 
of whole host lesion tissues reiterated an absence of innate immune responses in lesions. There 223 
was also increased expression of α2-macroglobulin-like 1, a protein potentially involved in 224 
bacterial immune evasion and bacterial survival, as well as increases in keratin 6A and 225 
interleukin 1β (Scholey et al., 2013). 226 
 227 
Molecular pathogenesis of digital dermatitis 228 
Recent work has isolated and compared commensal bovine gastrointestinal tract 229 
treponemes with bovine DD treponemes and identified these microorganisms as belonging to two 230 
large separate phylogenetic clusters (Evans et al., 2011b). Bovine DD treponemes belong to a 231 
proteolytic, serum-dependent cluster whose members have a gene encoding tissue attachment 232 
machinery and demonstrated haemolytic ability, whilst the bovine gastrointestinal treponemes 233 
belonged to a saccharolytic cluster which do not require or were inhibited by serum, do not have 234 
a gene encoding tissue attachment machinery and do not exhibit haemolysis. A previous review 235 
has detailed likely pathogenic mechanisms through comparison with human oral treponemes 236 
(Edwards et al., 2003a). These include a large number of shared cell surface proteins important 237 
for binding the host extracellular matrix (ECM). In a study of two DD treponeme strains, the 238 
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bacteria bound to a panel of mostly skin ECM proteins, including fibronectin, laminin, collagen 239 
type I, gelatin and keratin (Edwards et al., 2003b). 240 
 241 
Inflammatory dysregulation is also considered to make a key contribution to treponemal 242 
pathogenesis (Radolf et al., 2006). As aforementioned, the treponemes appear to allow immune 243 
evasion by downregulating key inflammatory markers in macrophages (Zuerner et al., 2007) 244 
whilst causing increased expression of substantial inflammatory markers in fibroblasts (Evans et 245 
al., 2014). Interestingly the treponeme-mediated increase in macrophage elastase production by 246 
fibroblasts should enable degradation of elastin, a key ECM protein responsible for skin integrity 247 
(Evans et al., 2014). 248 
 249 
Infection reservoirs and risk factors 250 
In a comprehensive PCR study of the presence of bovine DD treponemes in the dairy 251 
farm environment, in bovine tissues and gastrointestinal tract content, DD treponemes were 252 
occasionally present in two non-pedal bovine regions, the oral cavity (14.3% of cattle tested) and 253 
the rectum (14.8% of cattle tested) (Evans et al., 2012b). Interestingly, single phylotypes were 254 
detected in the oral cavity, whilst two rectal tissues yielded DNA from multiple DD treponeme 255 
phylotypes. In contrast, all farm environmental samples, including faeces, together with insects 256 
and gastrointestinal tract content samples, were negative using bovine DD treponeme PCR 257 
assays. Since DD treponemes were present in non-pedal tissues in only a small number of 258 
samples and animals, they do not appear to be part of the typical treponeme microbiota of the 259 
bovine gastrointestinal tract. Interestingly, there was a significant association between rectal 260 
presence of T. phagedenis-like DD treponemes and the housing period. Given the housing 261 
association for both carriage at the rectoanal junction and the occurrence of DD (Murray et al., 262 
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1996; Somers et al., 2005), similarities could be drawn with Brachyspira spp., pathogenic 263 
spirochaetes responsible for pig dysentery which are spread by the faecal oral route, with 264 
increased infection prevalence resulting from group housing (Haggman et al., 2013; Weber et al., 265 
2013). Further studies are required to characterise the contribution of oral and rectal carriage of 266 
DD treponemes to BDD transmission. 267 
 268 
Given parallels with the non-venereal human skin treponematosis, yaws, where touch is 269 
implicated in transmission (Antal et al., 2002), direct skin-to-skin contact may be a major route of 270 
transmission of DD treponemes. Recently, foot trimming equipment has been implicated as an 271 
important transmission route for DD treponemes, which were identified on the knife blade both 272 
before and after disinfection in some cases (Sullivan et al., 2014). Since hoof trimming provides 273 
both a direct method of contact, as well as exposure to potentially infected cattle foot tissues, this 274 
may well be an important mechanism by which the DD treponemes gain easy access to host 275 
tissues and are able to initiate disease. The recently identified chronic necrotic horn lesions might 276 
be considered to be a direct cause of such transmission (Sullivan et al., 2014). 277 
 278 
Another newly described transmission route may be M4.1, a chronic stage of the DD 279 
lesion with an active painful M1 focus. It has been suggested that healed M4 lesions can revert to 280 
this state because the lesion was not treated effectively in the first instance and then the infectious 281 
agents can be passed from animal to animal again (Berry et al., 2010, 2012). 282 
 283 
These newly identified infection reservoirs give a biological basis for many of the well-284 
established risk factors identified from epidemiology based studies (Table 2). Importantly, these 285 
infection reservoirs validate previously identified important risk factors and allow a more 286 
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thorough argument for better preventative farm management strategies. Indeed, these identified 287 
transmission routes can be readily targeted through farm management practices such as better 288 
hygiene and thus the results need to be heeded and utilised. 289 
 290 
Treatment and control 291 
Given the plethora of data now supporting treponemes as causal of DD, it would be 292 
reasonable to propose that treponeme targeted antibiotics, vaccines or transmission blocking may 293 
allow for reduction or even eradication of this disease. 294 
 295 
Towards effective antibiotic treatment 296 
In an excellent review of DD treatment strategies that explained both relevant research 297 
and implementation difficulties, Laven and Logue (2006) identified a lack of peer reviewed 298 
published articles describing controlled clinical trials of DD treatment and that relevant research 299 
was urgently needed (Laven and Logue, 2006). To assist decisions regarding antibiotic choice on 300 
farms, in vitro antimicrobial susceptibility data can be most useful and there have now been 301 
several such studies on DD treponemes (Evans et al., 2009a, 2012a; Yano et al., 2010a). These 302 
studies clearly identified the most effective antibiotics for use against DD treponemes as 303 
penicillin, penicillin derivatives (such as amoxicillin and ampicillin) and the macrolides 304 
erythromycin, azithromycin and gamithromycin. Treponemes were least susceptible to 305 
sulphamethoxazole, trimethoprim, cefalexin and colistin, and those antibiotics with intermediate 306 
susceptibility values included lincomycin, spectinomycin, oxytetracycline, ceftiofur and 307 
gentamicin (Evans et al., 2009a, 2012a; Yano et al., 2010a). 308 
 309 
Page 14 of 40
Since many commonly used/licensed DD antibiotic treatments have only intermediate 310 
treponeme antimicrobial susceptibility values, whilst some healing does occur likely resulting 311 
from limited activity against treponemes and destruction of secondary invaders, it is unsurprising 312 
that DD frequently recurs. Indeed the newly described DD disease stage (M4.1) is specifically 313 
associated with the topically applied, frequently used, antibiotics oxytetracycline and lincomycin 314 
(Berry et al., 2010, 2012) with intermediate DD treponeme susceptibilities (Evans et al., 2009a). 315 
Thus, M2 lesions treated with such products can result in M4 lesions which can reactivate to 316 
M4.1 lesions (Berry et al., 2010, 2012). 317 
 318 
In Tables 3 and 4, antibiotic clinical trials are compared with DD treponeme antimicrobial 319 
susceptibilities and treatments of human treponematoses. In agreement with DD treponeme 320 
antimicrobial susceptibility data, penicillin and azithromycin have been used effectively to treat 321 
the human treponematoses, syphilis and yaws, with nearly 100% clinical cure and little 322 
recurrence. Long acting penicillin was used to nearly eradicate yaws by the world health 323 
organisation (WHO) in the 1960s and now azithromycin is being used by the WHO to finally 324 
achieve eradication (Giacani and Lukehart, 2014). 325 
 326 
Given the success of human treponeme treatments with antibiotics, it has been proposed 327 
that comparable clinical trials with these antibiotics could effectively cure DD (Evans et al., 328 
2012a). As shown in Tables 3 and 4, some known treatment approaches for human 329 
treponematoses have been repeated in cattle, although either with different application methods, 330 
shorter treatment durations or substantially reduced antibiotic quantities. These sub-optimal 331 
bovine treatment trials were likely to have been driven by growing concerns about antibiotic 332 
overuse in farm animals and to minimise the quantity of milk that needs to be discarded 333 
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according to relevant legislation. However, given that these treatments are very effective against 334 
human trepanematoses with little or no disease recurrence (Tables 3 and 4), the data suggests it is 335 
highly likely they should be efficacious in cattle. 336 
 337 
For human treponematoses, only antibiotics with the highest treponemal susceptibilities 338 
are commonly used either by systemic injection or oral administration. For DD the most common 339 
antibiotic treatment is topical with antibiotics of intermediate susceptibilities. The time at/above a 340 
microorganism’s inhibitory concentration is a key pharmacodynamic parameter for β-lactam 341 
activity against another pathogenic spirochaete, Borrelia burgdorferi (Wormser and Schwartz, 342 
2009). In treatment of human treponematoses, the aim is to maintain a minimum serum penicillin 343 
concentration of 0.03 U/mL for 7-10 days in early infections (and 15-20 days in latent infections) 344 
(WHO, 1982). Aqueous procaine penicillin G (APPG) provides appropriate penicillin serum 345 
levels in humans when 600,000 U (~10,000 U/kg) a day are administered; hence, a 10 day course 346 
for syphilis is used (Table 3). However, penicillin preparations with slower absorption rates have 347 
been used preferentially in humans, as they only require single doses. 348 
 349 
Two preparations, procaine penicillin G in oil with aluminium monostearate (PAM) and 350 
benzanthine penicillin G (BPG), provide the correct prolonged serum penicillin dosage with 351 
single injection for treatment of the human treponematoses. Whilst PAM is no longer widely 352 
available, BPG has become the antibiotic of choice for human syphilis (2.4 million units, 353 
effective levels 3-4 weeks) and yaws (1.2 million units, effective levels, 1 week) (WHO, 1982). If 354 
these treatments and criteria are then compared with those of β-lactam field trials against DD, the 355 
studies of Read and Walker (1998), which showed good cure rate but substantial recurrence rate, 356 
used too short a treatment, only using 3 days of APPG or ceftiofur. It might be anticipated that, if 357 
Page 16 of 40
used at an appropriate concentration for longer periods (7-10 days), these treatments might 358 
provide a more optimal cure with little recurrence. In that study, the superior results of APPG 359 
over ceftiofur are in agreement with reported in vitro data, where ceftiofur requires a higher 360 
concentration to be bactericidal (Evans et al., 2012a). Further evidence supporting prolonged 361 
penicillin use is a study using cefquinome, another β-lactam, where a 5 day rather than 3 day 362 
treatment resulted in a more effective treatment of DD (Laven, 2006) with the authors suggesting 363 
further injectable antibiotic studies were needed and a subsequent case report which reported 364 
potential eradication with long acting ceftiofur (Bell, 2011). 365 
 366 
For macrolide DD studies (Table 3), systemic erythromycin (injection) was comparable 367 
with the efficacy of footbath erythromycin (Laven, 2006). However, whilst considered 368 
efficacious, erythromycin footbaths resulted in significant improvement of DD lesions in only 369 
60% of animals (Laven and Proven, 2000). In human beings, a minimum of 20 g erythromycin 370 
distributed over 10 days orally were required for effective cure of syphilis (Fernando, 1969). 371 
Subsequently, a recent study has shown azithromycin in single oral dose at 30 mg/kg has an 372 
excellent cure rate against yaws. Unfortunately, this highly efficacious dose is a three-fold 373 
increase per kg on the only erythromycin systemic trial in cattle thus far (Laven, 2006). It is clear 374 
that further trials are needed for reappraisal of antibiotic selection, application, dose, treatment 375 
time and licensing. 376 
 377 
If treatments are not effective on all animals on a farm, then lesion recurrence might 378 
represent reinfection or treatment failure. In syphilis and yaws, all patient contacts are treated, 379 
which is interesting if considering housed dairy cattle, where all animals might be considered 380 
contacts, especially given the high stocking densities on many farms. For treatment of yaws, the 381 
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WHO treats the entire population if the active case prevalence is > 10% (WHO, 1982). Given that 382 
DD is endemic in many countries and the prevalence is typically 20-30% in each herd (Holzhauer 383 
et al., 2006; Capion et al., 2008; Barker et al., 2009; Cramer et al., 2009), this suggests whole 384 
herd treatment is required on many farms regionally to allow effective treatment and to stop 385 
reinfection. Furthermore, in human treponematoses, both clinical and serological cure are 386 
generally used in treatment criteria/outcomes (Brown, 1985; Parkes et al., 2004). 387 
 388 
When DD was first reported in the UK and USA, there was clear serological distinction 389 
between infected and naïve animals, even on the same farms (Walker et al., 1997; Demirkan et 390 
al., 1999). However, more recent studies suggest that all the animals in a herd are frequently 391 
exposed and seroconvert (Vink et al., 2009). Thus, if we only treat active clinical manifestations, 392 
microorganisms may be present in other animals subclinically and their serological status may 393 
indicate if treatment is recommended. 394 
 395 
In most studies on topical antibiotic treatments, cure rates after 1 month for topical 396 
antibiotic treatments of DD tend to be ~60-70% (Holzhauer et al., 2011). One recent study 397 
reported no significant difference between DD treatment with lincomycin or oxytetracycline (73 398 
and 68% cure, respectively) (Berry et al., 2010). Whilst this could be considered efficacious, this 399 
is not comparable to success rates in treating human treponematoses. Furthermore, rates of 400 
recurrence of ~50% have been reported in cattle with DD during 12 month follow up (Berry et 401 
al., 2012). In addition, the underlying tissue pathology of many considered cured lesions at 1 402 
month after treatment were suggestive of disease reinitiation (Berry et al., 2010). 403 
 404 
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Clearly, current antibiotic use with only intermediate susceptibilities from topical (not 405 
systemic) applications will only maintain DD lesions, since they are not properly treated and are 406 
likely to result in maintenance of an M4/M4.1 infection reservoir and therefore increase disease 407 
spread. Historically, it is understandable how topical antibiotics have come to be commonly used, 408 
as they demonstrate some efficacy, are not as environmentally polluting as footbaths and, at least 409 
for oxytetracycline, are not considered to enter the animal’s milk (Britt et al., 1999). However, 410 
given the general failure of current treatments to reduce DD on farms, resulting in the disease’s 411 
endemic status in many countries globally, clinical trials are needed to demonstrate whether the 412 
common treatments for human treponematoses may work, even if they do not immediately 413 
translate to actual farm use due to milk withdrawal times. From such a benchmark, there could 414 
then be development of novel antibiotics not entering the animal’s milk supply that are effective 415 
against DD. Given the continual use of relatively ineffective antibiotic treatments and how much 416 
DD costs financially, if an eradication program farm by farm or region by region could be 417 
considered, this might be the best way to control this disease and, in the long term, would be 418 
more beneficial for environment, animal welfare and economically. However, given the WHO 419 
includes macrolides as a ‘highest priority’ critically important antimicrobial (CIA) for human 420 
medicine and penicillin as a CIA also (WHO, 2011), the veterinary antimicrobial prescriber 421 
currently faces a substantial challenge in terms of the routine treatment of DD with these most 422 
relevant antimicrobials. 423 
 424 
Non-antibiotic control strategies 425 
A bacterin vaccine was developed based on a two treponeme phylotypes, which showed 426 
initial promise but subsequently produced poorer results and was withdrawn from market (Keil et 427 
al., 2002; Ertze et al., 2006). As we now know, DD lesions typically contain several (≥3-5) 428 
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treponeme phylotypes (Klitgaard et al., 2008; Nordhoff et al., 2008; Evans et al., 2009c), so it is 429 
maybe not surprising that a dual phylotype vaccine failed. Given that some phylotypes remain 430 
uncultivable, the use of targeted gene sequencing and recombinant vaccine production could 431 
allow for a multivalent vaccine to be produced in the near future that is representative of multiple 432 
treponeme phylotypes and therefore is more efficacious. However, given that it has been shown 433 
that four T. phagedenis-like isolates from DD lesions varied in virulence and antigenicity in vivo 434 
(Elliott et al., 2007) further studies are needed to characterise such diversity to ensure that any 435 
vaccine candidate identified would allow for effective DD protection. 436 
 437 
Towards using farm management to control DD, when taking risk factors (Table 2) into 438 
consideration, many issues need to be addressed, including better on-farm housing hygiene, 439 
access to pasture, a balanced diet, regular footbathing and hoof trimming with appropriately 440 
disinfected equipment. Purchasing new stock from herds with no history of DD or ensuring 441 
bought animals have no evidence of DD, whether active or healed, would help to reduce the risk. 442 
Further characterisation of infection reservoirs and transmission routes in the future may allow 443 
for even better farm management of DD or even removal of specific infection reservoirs. 444 
 445 
Worries about antibiotic use in farm animals means that footbaths have been developed to 446 
offer an alternative and their use is associated with a reduced risk of DD (Rodriguez-Lainz et al., 447 
1999). Given the lack of tissue penetration, it is unlikely footbaths can be used to eradicate DD; 448 
however, together with other farm management practices, they may help to reduce transmission 449 
and allow some healing. Table 5 shows a selection of commonly used footbath solutions with 450 
associated efficacies. Copper sulphate is widely used and does show some efficacy. In one study, 451 
copper sulphate was more effective than formalin (Teixeira et al., 2010), whilst another 452 
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demonstrated a comparable cure rate for both, but copper sulphate reduced risk of development 453 
of new lesions (Holzhauer et al., 2012). More frequent treatment with copper sulphate has been 454 
reported to increase efficacy (Speijers et al., 2012), as does treatment for a longer duration 455 
(Logue et al., 2012). 456 
 457 
Unfortunately, the widely used footbath chemicals copper sulphate and formalin are 458 
environmentally damaging and carcinogenic respectively, with legislative bodies beginning to 459 
ban/limit their use for these reasons, suggesting that they may have limited future capability. As a 460 
result, several alternative products have been developed, some of which are comparable in 461 
efficacy to copper sulphate (Teixeira et al., 2010; Smith et al., 2014). There is little data provided 462 
on recurrence of DD with the use of footbaths (Table 5) and continual regular use is required to 463 
keep the prevalence of DD as low as possible (Blowey, 2010). Interestingly, an in vitro method 464 
has been developed to assay footbath solutions against DD treponemes (Hartshorn et al., 2013). 465 
This study assesses the interaction of footbath solutions with both faeces and microbes, and could 466 
be a useful tool in future product development. Interestingly, the efficacy of copper sulphate was 467 
severely diminished in the presence of 20% manure, with several alternatives performing better 468 
under this condition. 469 
 470 
A variety of non-antimicrobial topical treatments other than footbath solutions have been 471 
discussed in a previous relevant review, with many performing no better than tap water (Laven 472 
and Logue, 2006) and the most efficacious being very labour intensive; for example triplicate 473 
application for 21 days (Britt et al., 1996). Obviously, for any practical treatment, minimal labour 474 
is required. Table 5 details recent studies showing the efficacy of several solutions with 475 
corresponding regimens. Several treatments now give comparable or better results than topical 476 
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antibiotic spray. Unfortunately, follow up studies are not described for the majority of studies and 477 
recurrence may be considerable given tissue penetration problems with topical applications. 478 
Whilst most topical treatments involve antiseptics (Table 5), more recently there have been novel 479 
approaches, such inducing sloughing of necrotic skin with salicylic acid (Schultz and Capion, 480 
2013) or increasing the general hygiene of cows with specifically designed washing systems 481 
(Thomsen et al., 2012). 482 
 483 
Conclusions 484 
Bovine DD has been with us for at least 30 years and, unless drastic changes to treatment 485 
and control can be made, it is here to stay. Given associated animal welfare issues and substantial 486 
costs to farmers and the wider economy, substantially more research is needed into this severe 487 
infectious disease towards eradication. Studies into appropriate systemic antibiotic use might 488 
allow for eradication and stop the continued overuse of less efficacious antibiotics and 489 
environmentally damaging footbath solutions. Further studies are needed worldwide to allow for 490 
more comprehensive investigations of infection reservoirs and transmission studies. Genomics 491 
and proteomics studies are needed to identify relevant vaccine candidates. In the future, 492 
hopefully, we may be able to finally prevent this disease by vaccines, good farm practice and/or 493 
effective treatment. 494 
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 Table 1 1056 
Current bovine digital dermatitis scoring system with pathological descriptions. 1057 
 1058 
Risk factors Macroscopic description Underlying pathology 
M1 A small focal active red/grey circumscribed 
lesion < 2 cm wide with 1 mm wide red foci 
(Dopfer et al., 1997) 
Partial epithelium loss; tissue degradation with fibrin islands; hyperplastic stratum 
corneum; acanthotic stratum spinosum; dermal perivascular infiltration with 
neutrophils and mononuclear cells located in the dermis and epidermis (Read and 
Walker, 1994, 1998; Dopfer et al., 1997) 
M2 A painful large ulcerative, red/grey active 
lesion > 2 cm wide (Dopfer et al., 1997) 
Stratum corneum now absent; haemorrhages at lesion edge; increased degradation 
and acanthosis; rete ridge formation; microabscesses; increased dermal perivascular 
infiltration; in the epidermis there are now mostly eosinophils and neutrophils (Read 
and Walker, 1994, 1998; Dopfer et al., 1997) 
M3 A healing, painless brown scab; typically seen 
after treatment (Dopfer et al., 1997) 
Not determined 
M4 A chronic stage presenting as dyskeratosis or 
irregular proliferative hyperkeratotic 
overgrowths (Dopfer et al., 1997) 
Highly proliferative epidermis with rete ridge formation and pronounced stratum 
corneum hyperplasia, acanthosis of the stratum spinosum; numerous horny columns 
surrounded by haemorrhages/cell detritus; stratum granulosum shows empty 
vacuoles, more neutrophils than mononuclear cells in epidermis, many plasma cells 
in dermis (Read and Walker, 1994, 1998; Dopfer et al., 1997) 
M4.1 A chronic stage with active, painful M1 focus 
(Berry et al., 2012) 
Not determined 
M5 or M0 Healthy skin with no evidence of previous 
lesion (Berry et al., 2012) 
Not determined 
 1059 
1060 
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 Table 2 1061 
Identified risk factors for bovine digital dermatitis (DD), with underlying pathobiological basis. 1062 
  1063 
Risk factors Association with DD presence Underlying pathobiological basis 
Foot hygiene Increased muddiness of environment associated with an 
increased risk of DD compared with less muddy environment 
(Rodríguez-Lainz et al., 1996a; Rodríguez-Lainz et al., 1996b). 
Required maceration (continual exposure to moisture) of skin required 
to transmit DD in experimental model (Gomez et al., 2012; Read and 
Walker, 1996). Presence of digital dermatitis treponemes in the bovine 
GI tract suggests faecal shedding (Evans et al., 2012b) 
 Increased animal hygiene associated with a reduced risk of DD 
(Hultgren and Bergsten, 2001) 
As above 
 Footbathing reduces the risk of DD compared to farms that do 
not footbath (Rodriguez-Lainz et al., 1999) 
Decreases exposure of feet to unhygienic conditions. As above 
Claw trimming Lack of washing hoof trimming equipment between cows 
increased the risk of DD (Wells et al., 1999) 
Disease considered highly contagious and transmitted through hoof 
trimming equipment (Wells et al., 1999). Presence of DD treponemes 
identified frequently on hoof trimming equipment (Sullivan et al., 
2014a) 
 Use of a primary hoof trimmer who trimmed cows hooves on 
other operations increases the risk of DD (Wells et al., 1999) 
Disease considered highly contagious and transmitted through hoof 
trimming equipment (Wells et al., 1999). Presence of DD treponemes 
identified frequently on hoof trimming equipment even after 
disinfection in some cases (Sullivan et al., 2014a) 
 Regular claw trimming twice a year reduces the risk of DD 
compared with longer durations between trimming (>7 months) 
(Somers et al., 2005) 
Hoof trimming considered important for ruminant foot health since it 
reduces mechanical pressures (Toussaint Raven, 1985) 
Housing and 
land access 
Cows kept on pasture have a decreased risk of DD than cows 
housed indoors (Blowey and Sharp, 1988; and Rodríguez-Lainz 
et al., 1996b; Onyiro et al., 2008). 
Increases exposure of cows to poor hygiene and moist foot conditions, 
which are a risk factor as above 
 Cows with daily access to pasture in winter have a decreased risk 
of DD compared to those animals which do not (Wells et al., 
1999) 
Increases exposure of cows to poor hygiene and moist foot conditions, 
which are a risk factor as above 
Heifer 
replacement 
Buying in new heifers increases the risk of DD (Rodriguez-Lainz 
et al., 1996; Wells et al., 1999) 
Since DD is considered to be a contagious infectious disease, it can be 
introduced with affected heifers (Read and Walker, 1998). DD 
asymptomatic animals harbouring DD treponemes in rectal tissues may 
shed DD treponemes and therefore transmit infection (Evans et al., 
2012b). Macroscopically healed lesions may reactivate and cause 
subsequent spread (Berry et al., 2012; Berry et al., 2010) 
Flooring type Grooved concrete > Smooth/slatted concrete > Textured concrete 
for increased risk of DD (Wells et al., 1999) 
Abrasiveness or slipperiness of concrete (Wells et al., 1999) 
 Increased risk of DD from solid floor compared to use of rubber-
slatted flooring (Hultgren and Bergsten, 2001) 
Improved hygiene at the rear end of cows due to optimal flooring 
allowing drainage of urine and faeces (Hultgren and Bergsten, 2001) 
 Increased risk of DD from solid floor compared to use of slatted 
flooring with scraper system (Somers et al., 2005) 
Regular removal of manure reduces unhygienic moist conditions 
(Somers et al., 2005) 
Nutrition Cows receiving maximum concentrate supplement 2 weeks after 
calving are at increased risk of DD compared to those receiving 
their maximum concentrate supplement at 3 weeks (Somers et 
al., 2005) 
Excessive concentrate shortly after calving may enhance the postnatal 
metabolic imbalance. Higher metabolic stress increases susceptibility to 
diseases and therefore DD (Enevoldsen et al., 1994) 
 Feeding of by-products (Somers et al., 2005) By-products are typically protein-rich and may cause an inappropriate 
diet with excessive protein intake identified as a potential risk factor for 
DD previously (Somers et al., 2005) 
 Animals with a body condition score too high or low have a 
higher risk of developing DD (Schopke et al., 2013) 
Inappropriate diet weakens immune system, resulting in an increased 
susceptibility to infectious diseases (Schopke et al., 2013) 
Parity First parity cows have increased risk of DD (Read and Walker, 
1998; Rodriguez-Lainz et al., 1999; Somers et al., 2005) 
Primiparous cows exposed to severe changes in nutrition and 
environment in the period surrounding calving (Somers et al., 2005) 
and considered to have less immunity (Blowey et al., 1994; Read and 
Walker, 1998) 
Lactation Increased risk of DD during lactation than dry period (Read and 
Walker, 1998; Murray et al., 2002; Somers et al., 2005) 
Lactating cows frequently shed more liquid faeces due to diet, whereas 
dry cows excrete solid faeces, since they are fed a higher proportion of 
roughage. Liquid faeces are associated with more unhygienic and moist 
floor conditions (Somers et al., 2005) 
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 Table 3 1064 
Comparison of bovine digital dermatitis (DD) treatment clinical trials, DD treponeme antibiotic in vitro susceptibility data and known effective treatments for 1065 
human trepanemotoses: Systemic treatment. 1066 
 1067 
DD Treatment Response Recurrence MBC90
 a References Human treponematoses treatment b Response Recurrence References 
Aqueous procaine 
penicillin G, IM, 3 
days, 18,000 U/kg, 
twice daily 
Highly responsive, 
all (100%) healed 
Yes, in 25% of 
cases, 7-12 
weeks after 
healing 
0.1875 Read and Walker (1998) Early syphilis: Procaine penicillin 
IM 600,000 units/day once daily for 
10 days  
Highly responsive 
(100% cured) 
None Idsoe et al. (1972) 
     Early syphilis: Penicillin G 
benzanthine 2.4 MU, single 
injection 
Highly responsive 
(97% cured) 
1% after 2 years Smith et al. (1956) 
     Yaws: Penicillin G benzanthine 1.2 
MU, single injection 
Highly responsive 
(96% cured) 
1.5% after 6 
months 
Grin et al. (1954) 
Ceftiofur sodium, 
IM, 3 days, 2 mg/kg, 
daily 
Highly responsive, with 
87% healed 
Yes, in 27% of 
cases, 7-12 
weeks after 
healing 
24 Read and Walker (1998) - - - - 
Cefquinome, IM, 
either 3 days or 5 
days 1 mg/kg 
5 days cefquinome lesion 
scores better than 3 day 
use or erythromycin 
footbath 
Not reported Not 
reported 
Laven (2006) - - - - 
Erythromycin, IM, 
10 mg/kg, day 1 
Lesion scores 
comparable to 
erythromycin footbath 
but not as good as 
cefquinome 
Not reported 0.1875 Laven (2006) Alternative to penicillin for early 
syphilis: Erythromycin, oral, 500mg 
per 6 hours for 10 days (total 20g) 
Highly responsive 
(100% cured) 
None Fernando (1969) 
     Penicillin alternative for early 
syphilis: Azithromycin, oral, 1 g 
initially, then 500 mg daily for 8 
days 
Highly responsive 
(100% cured) 
None Gruber et al. (2000) 
     Also note recently reported 
penicillin alternative for yaws: 
Azithromycin, oral, 30 mg/kg, day 1 
Highly responsive 
(96% cured 
compared to 95% in 
benzanthine 
Penicillin G group) 
None Mitja et al. (2012) 
 1068 
a Reported using in vitro susceptibility testing of DD treponemes as described by (Evans et al., 2009a, 2012a) whereby in those studies the cumulative susceptibility results across all BDD spirochaetes 1069 
tested are expressed as MBC90, the concentration at which 90% of digital dermatitis associated spirochaetes are killed. 1070 
b Average weight of a mature Holstein Friesian cow is 680 kg and average weight of a human being is 62 kg. 1071 
1072 
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 Table 4 1073 
Comparison of bovine digital dermatitis (DD) treatment clinical trials, DD treponeme antibiotic in vitro susceptibility data and known effective treatments for 1074 
human trepanemotoses: Topical treatment. 1075 
 1076 
 1077 
1078 
DD Treatment Response Recurrence MBC90
 a References Human treponematoses treatment b Response Recurrence References 
Oxytetracycline, 
single treatment with 
bandage, 5 mL 
applied at 100 g/L 
Cure rate at day 29 was 
13·8% for primiparous 
and 38·7% in 
multiparous cows 
Not described 6 Nishikawa and Taguchi 
(2008) 
Oxytetracycline, 2 g orally for 5 
days 
Highly responsive, 
Clinical cure at 3 
months 
Not described Loughlin et al. (1951) 
Oxytetracycline, day 
1 with bandage, 5 
mL applied at 100 
g/L, treatment 
repeated day 6 and 
new bandage 
removed 2 days later 
Cure rate 87% at 32 days 
after treatment 
Not described 6 Manske et al. (2002) As above    
Lincomycin (10 g) or 
oxytetracycline (10 
g) paste, single 
treatment with 
bandage (day 1), 
bandage removed 
day 4 
Cure rates 73% at day 14 
and 68% at day 30; no 
significant difference 
between antibiotics 
Not described 
but 50% of 
cured lesions at 
day 30 were 
histologically 
considered 
active or 
incipient 
48 or 6 Berry et al. (2010) - - - - 
Lincomycin (10 g) 
paste, single 
treatment with 
bandage (day 1), 
bandage removed 
day 4, cows checked 
and retreated 
monthly for 1 year 
- High recurrence 
rate (54%) 
during 1 year 
follow up 
48 Berry et al. (2012) - - - - 
Lincomycin 0.5 g/L 
and spectinomycin 
1.0 g/L (50:50), 
spray once daily for 
10 days 
Only 1.0 g/L showed 
significant improvement 
day 12 and significant 
cure compared to control 
(66%) at days 30 and 90 
Not described 48/48 and a 
resistant 
isolate (> 
12,288) 
Berry and Maas (1997) - - - - 
Erythromycin 
footbath (0.035 g/L), 
day 1 
Assessed day 4 and 
lameness and several 
lesion scores were 
significantly better than 
control 
Not described 0.1875 Laven and Proven (2000) See oral erythromycin and 
azithromycin above. 
- - - 
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 Table 5 1079 
Comparison of recent non-antibiotic bovine digital dermatitis (DD) treatment clinical trials. 1080 
 1081 
 1082 
a Recurrence in this review is whether lesions recur after treatment had finished (not during). 1083 
 1084 
DD Treatment Response Recurrence a Mode of action References 
Footbath     
Copper sulphate, 2% (w/v), daily for 
7 days 
Comparable to 2 days erythromycin footbath treatment in 
reducing lesion score 
Not described Bactericidal 
antiseptic/disinfectant 
Laven and Hunt (2002) 
Copper sulphate, 5% and 2% (W/V), 
hypochlorite 2% (W/V) weekly 
Copper sulphate 5% (W/V) resulted in significantly less DD 
when compared with 2% (W/V) copper sulphate, 
hypochlorite or control 
Not described Bactericidal 
antiseptic/disinfectant 
Speijers et al. (2010) 
Formalin, 2.5% (W/V), daily for 7 
days 
Comparable to 2 days erythromycin footbath treatment in 
reducing lesion score 
Not described Bactericidal 
antiseptic/disinfectant 
Laven and Hunt 2002) 
Peracetic acid, 1% (V/V), daily for 7 
days 
Comparable to 2 days erythromycin footbath treatment in 
reducing lesion score 
Not described Bactericidal 
antiseptic/disinfectant 
Laven and Hunt 2002) 
Acidified copper sulphate, 4%, twice 
daily, 5 days a week; formalin 4%, 1 
day each fortnight 
Cure rates between treatments not different but risk of new 
lesions was three times less for copper sulphate 
Not described Bactericidal 
antiseptic/disinfectant 
Holzhauer et al. (2012) 
Dragonhyde, 5% (V/V), twice 
weekly for 4 weeks 
Dragonhyde is comparable to copper sulphate and better 
than formalin when comparing the number of DD lesions in 
each group 
Not described Bactericidal 
antiseptic/disinfectant 
Teixeira et al. (2010) 
Commercial footbaths containing 
glutaraldehyde, organic acids or 
quaternary ammonium compounds, 
twice weekly for 8 weeks 
Difference between treatment and control (in terms of cure 
and prevention) were not significantly different for any of 
the three treatments applied 
Not described Bactericidal 
antiseptic/disinfectant 
Thomsen et al. (2008) 
Organic acid footbath solution with 
tea tree oil, 3% (V/V), daily, 5 days 
a week for 9 weeks 
Organic acid footbath solution with tea tree oil is 
comparable to copper sulphate 5% (V/V) in decreasing the 
proportion of M1/M2 lesions 
Not described Bactericidal 
antiseptic/disinfectant 
Smith et al. (2014) 
Direct topical treatment     
Salicylic acid, 10 g applied with 
bandage, day 1 
Increased lesion healing and improvement when compared 
to chlortetracycline spray as a control 
Not described Sloughing of necrotic skin Schultz and Capion 2013) 
Protexin Hoof-Care (containing 
metallic salts and organic acids), 
days 1 and 4 
Reduced lameness effectively; comparable to 
oxytetracycline spray 
Not described Bactericidal 
antiseptic/disinfectant 
Kofler et al. (2004) 
Water-based gel with activated 
copper and zinc chelate, 5 g applied 
on days 1, 3 and 7 
Cure rate of DD lesions treated with gel chelate was 
significantly better than lesions treated with 
chlortetracycline 
At day 7 all M2 cured but 
recurrence/reinfection at days 
21 (2%) and 28 (8%) 
Bactericidal 
antiseptic/disinfectant 
Holzhauer et al. (2011) 
Non-antimicrobial cream, day 1 Reduced DD significantly compared to control; comparable 
to lincomycin spray 
Yes (percentage not clarified) Bactericidal 
antiseptic/disinfectant 
Moore et al. (2001) 
Automated hoof washing with water 
and 0.4% soap solution, daily, for 64 
days 
Reduced DD significantly compared to no washing Not described Tackling general foot hygiene 
of animals 
Thomsen et al. (2012) 
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